CORT Live-Signale | Maximieren Sie Profite mit Getagraph.com

VERKAUFEN 108194 min ago

@ $23.28

Ausgestellt: 14 Feb 2024 @ 15:30

Rendite: 0.73%

Vorheriges Signal: Feb 13 - 15:30

Vorheriges Signal: Kaufen

Rendite: 0.28 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 19:44):

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States...

Stats
Tagesvolumen	258 209
Durchschnittsvolumen	1.13M
Marktkapitalisierung	2.43B
EPS	$0 ( 2024-02-15 )
Nächstes Ertragsdatum	( $0.180 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	24.95
ATR14	$0.0320 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-10	Mahoney David L	Buy	27 806	Common Stock
2024-04-10	Mahoney David L	Buy	30 000	Common Stock
2024-04-10	Mahoney David L	Sell	2 194	Common Stock
2024-04-10	Mahoney David L	Sell	27 806	Common Stock
2024-04-10	Mahoney David L	Sell	30 000	Stock option (right to buy)

INSIDER POWER
62.30
Last 97 transactions
Buy: 1 925 494 \| Sell: 448 997

Volumen Korrelation

Lang: 0.16 (neutral)

Kurz: 0.28 (neutral)

Signal:(46.336) Neutral

Corcept Therapeutics Inc Korrelation

10 Am meisten positiv korreliert
SVAC	0.941
PAIC	0.916
TLGT	0.913
GETVV	0.897
RMRM	0.897
SVOK	0.891
MTSL	0.888
CERC	0.865
GOODM	0.854
FCFS	0.838

10 Am meisten negativ korreliert
AMRB	-0.968
NETE	-0.941
MMAC	-0.919
PFG	-0.901
LINC	-0.887
FFBW	-0.872
SRAC	-0.871
REG	-0.865
IOSP	-0.865
NOVT	-0.861

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Corcept Therapeutics Inc Korrelation - Währung/Rohstoff

-0.29
( neutral )

-0.43
( neutral )

0.00
( neutral )

0.29
( neutral )

-0.69
( moderate negative )

0.74
( moderate )

Corcept Therapeutics Inc Finanzdaten

Annual	2023
Umsatz:	$482.38M
Bruttogewinn:	$475.89M (98.66 %)
EPS:	$1.020

FY	2023
Umsatz:	$482.38M
Bruttogewinn:	$475.89M (98.66 %)
EPS:	$1.020

FY	2022
Umsatz:	$401.86M
Bruttogewinn:	$396.47M (98.66 %)
EPS:	$0.950

FY	2021
Umsatz:	$365.98M
Bruttogewinn:	$360.70M (98.56 %)
EPS:	$0.970

Financial Reports:

No articles found.

Corcept Therapeutics Inc

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.

Echtzeitaktualisierungen für Corcept Therapeutics Inc [CORT]

Upcoming Earnings Alert